For the media:
Shortage Drug Compounding and GLP-1s: What you need to know

☞ On deadline? For media inquiries CLICK HERE. 

Upcoming Events

December 4:  PCAC meeting on adding several bulk drug substances to the 503A Bulks List (2 of 2)

December 5: APC CE webinar: Compounding in Special Populations

December 5: CompoundED UpDATE Regional Meeting, Scottsdale, AZ

December 13: APC Board of Directors Meeting, Las Vegas

December 13-15: A4M Longevity Fest, Las Vegas

APC In the News

Not holding back:

We pull no punches in this article about Novo's latest shenanigans

Video appearance: APC talks the legal issues:

APC CEO Scott Brunner was a guest on "On The Pen" — a YouTube channel dedicated to all things GLP-1.

PharmExec features APC execs talking about the compounding process:

From the manufacturing process to patient and provider challenges, this PharmExec video interview covers all things compounding.

APC calls out Novo in Reuters:

Reuters used our comment that there's a difference between making molecules and compounding with them.

CBS quotes APC on resolving shortages:

Taking a different angle, this article looked how the FDA decides when to resolve a shortage.

The Brits could have done better:

UK-based pharmaphorum is covering the GLP-1 issue, but it played down our rather important point about the ease of compounding with the drugs.

Video: APC on Scripps:

APC CEO Scott Brunner appeared on the Scripps News show “America On The Docket,” talking about the “brewing legal battle” over compounded tirzepatide and semaglutide.

Tirzepatide fallout in The Hill:

The Hill writes one of the first stories on the fallout from the FDA's tirzepatide decision.

Click here for more examples of APC in the news

Support Compounding

Our Patrons